Literatura académica sobre el tema "HCT 116 Carcinoma"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "HCT 116 Carcinoma".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "HCT 116 Carcinoma"
Apaydin Yildirim Betul. "Anti-cancer, antiproliferative activity of active anionic H2O8 oxygen solution on HCT-116 cancer cell". World Journal of Advanced Research and Reviews 12, n.º 2 (30 de noviembre de 2021): 179–84. http://dx.doi.org/10.30574/wjarr.2021.12.2.0560.
Texto completoLeong, Lek Mun, Kok Meng Chan, Asmah Hamid, Jalifah Latip y Nor Fadilah Rajab. "Herbal Formulation C168 Attenuates Proliferation and Induces Apoptosis in HCT 116 Human Colorectal Carcinoma Cells: Role of Oxidative Stress and DNA Damage". Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–12. http://dx.doi.org/10.1155/2016/2091085.
Texto completoLeischner, Christian, Markus Burkard, Anja Michel, Susanne Berchtold, Heike Niessner, Luigi Marongiu, Christian Busch, Jan Frank, Ulrich M. Lauer y Sascha Venturelli. "Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status". Molecules 26, n.º 18 (14 de septiembre de 2021): 5586. http://dx.doi.org/10.3390/molecules26185586.
Texto completoChandrani, Jeenkal P. y Kalpesh J. Ganatra. "An Efficient And Catalytically Free Chemical Transformation of Pyrimidin-2(1H)-one to 2-(N-Arylamino)pyrimidines and their in vitro Cytotoxicity Evaluation". Asian Journal of Organic & Medicinal Chemistry 5, n.º 2 (2020): 133–37. http://dx.doi.org/10.14233/ajomc.2020.ajomc-p260.
Texto completoTan, Maria Carmens, Glenn G. Oyong, Chien Chang Shen y Consolacion Y. Ragasa. "CYTOTOXIC LABDANE DITERPENOIDS FROM ANDROGRAPHIS PANICULATA (BURM.F.) NEES". Asian Journal of Pharmaceutical and Clinical Research 10, n.º 12 (1 de diciembre de 2017): 99. http://dx.doi.org/10.22159/ajpcr.2017.v10i12.19194.
Texto completoBudu, Oana, Christian Dragos Banciu, Codruta Soica, Daniel Florin Lighezan, Andreea Milan, Alexandra Prodea, Alexandra Mioc, Marius Mioc, Gabriel Mardale y Laurentiu Sima. "Lacticaseibacillus rhamnosus—A Promising Tool for Colorectal Cancer Treatment". Processes 11, n.º 3 (6 de marzo de 2023): 781. http://dx.doi.org/10.3390/pr11030781.
Texto completoVaziri, S. A., A. Al-Hazzouri, D. R. Grabowski, M. K. Ganapathi, R. M. Bukowski y R. Ganapathi. "Sorafenib treatment of clear-cell renal cell carcinoma (CCRCC) and colorectal carcinoma (CRC) cells: Differential effects on gene expression and cell death pathways". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 15612. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15612.
Texto completoKhulud M Alshehr y Madeha O I Ghobashy. "Antitumor, Antimicrobial activities and Phytochemicals Constituent of different Extracts of Pulicaria undulata (Forssk.) Oliver. Grown Naturally in Saudi Arabia". International Journal of Research in Pharmaceutical Sciences 11, n.º 3 (11 de agosto de 2020): 4889–901. http://dx.doi.org/10.26452/ijrps.v11i3.2790.
Texto completoKanti Das, Sabuj, Snehasis Mishra, Krishnendu Manna, Utpal Kayal, Supratim Mahapatra, Krishna Das Saha, Sasanka Dalapati, G. P. Das, Amany A. Mostafa y Asim Bhaumik. "A new triazine based π-conjugated mesoporous 2D covalent organic framework: itsin vitroanticancer activities". Chemical Communications 54, n.º 81 (2018): 11475–78. http://dx.doi.org/10.1039/c8cc07289b.
Texto completoJacinto, Sonia D., Eunice Alexis C. Chun, Anthony Sebastian Montuno, Chien-Chang Shen, Dinah L. Espineli y Consolacion Y. Ragasa. "Cytotoxic Cardenolide and Sterols from Calotropis Gigantea". Natural Product Communications 6, n.º 6 (junio de 2011): 1934578X1100600. http://dx.doi.org/10.1177/1934578x1100600614.
Texto completoTesis sobre el tema "HCT 116 Carcinoma"
Kashyap, Srishti. "Isolation, Structure Elucidation and Functional Characterization of a Novel Cytotoxic Secondary Metabolite Phomafuranone, 2-Hydroxy-2, 4-dimethyl-5-[-1-propen-1-yl]-3(2H)-furanone, from Phoma tropica an Endophytic Fungus Isolated from Mappia foetida". Thesis, 2017. http://etd.iisc.ac.in/handle/2005/4135.
Texto completoChung, Ming-Hsien y 鍾明憲. "Positron Emission Tomography-based study in Hepatocellular carcinoma: 18F-FDG and 11C-MET uptake in HCC cell line". Thesis, 2011. http://ndltd.ncl.edu.tw/handle/78026005703905063226.
Texto completo國防醫學院
生物及解剖學研究所
99
Hepatocellular carcinoma (primary liver malignancy or called hepatoma) is the most common type of liver cancer. In Taiwan, the incidence of hepatoma has been estimated to be 27.7 of 100,000 peoples every year. It ranks the first and second cancer-related death in male and female, respectively. The clinical assessment tools for patients with hepatoma include serum alpha-fetoprotein (AFP) check up and several modalities of imaging study. The latter ones consist of sonography, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET). Among which, PET is useful to survey tumor metabolism by using different tracers. In clinical practice 18F-Fluoro-deoxyglucose (FDG) is the most commonly used oncological PET tracer. Most cancer cells can accumulate FDG via membrane glucose transporter and phosphorylation of FDG by enriched hexokinase expression, thus allowing the FDG-avid tumor cells to be detected by PET. However FDG is not a completely satisfied tracer for hepatomas because of the various expression of glucose-6-dephosphatase (G6PD) inherent to hepatocytes, which may evacuate the tracer from tumor cells once FDG is de-phosphorylated by G6PD. The G6PD activity varies in hepatomas with different differentiation and therefore affects the detection rate of FDG PET. Alternative PET tracers such as 11C-acetate and 11C-choline have been proposed and their use to detect certain non-FDG-avid hepatomas has been reported preliminarily. Our previous study has demonstrated the use of 11C-methionine (Met) to localize hepatomas. Briefly we found that the primary hepatomas showed Met-void while extra-hepatic hepatomas presented as Met-avid lesions. Conversely the intra-hepatic Met-void lesion showed FDG avidity. To further explore the related mechanism, the study of in vitro Met uptake in hepatomas was performed using three different cell lines (HepG2, Hep3B, HA59T). Also two known differentiation modifiers including All-trans retinoic acid (ATRA) and Trichostatin A (TSA) were adopted to intervene the hepatomas. Met and FDG uptake in ATRA- or TSA-treated hepatomas were compared and correlated with the pertinent tumor growth. The result showed that all these three cell-lines shared the response of growth arrest as well as increased apoptotic potential with either ATRA or TSA treated hepatoma cells in vitro. Their FDG uptake was significantly lowered and Met uptake was enhanced in presence of TSA. The change followed a dose-depend manner. With ATRA treatment, dose-dependent increased Met uptake was also demonstrated in hepatomas. However there was similar change of FDG uptake in ATRA-treated hepatomas. In conclusion Met uptake in hepatomas can be regulated by ATRA or TSA treatment and whether it is related to the effects of differentiation or anti-tumor activity known for ATRA or TSA remains uncertain. The role of Met uptake as a biomarker for hepatoma therapeutics related research warrants for further study.
Actas de conferencias sobre el tema "HCT 116 Carcinoma"
Šeklić, Dragana, Milena Jovanović, Nevena Milivojević y Marko Živanović. "PLATINUM(IV) COMPLEX AND ITS CORRESPONDING LIGAND SUPPRESS CELL MOTILITY AND PROMOTE EXPRESSION OF FRIZZLED-7 RECEPTOR IN COLORECTAL CANCER CELLS". En 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac, 2021. http://dx.doi.org/10.46793/iccbi21.288s.
Texto completoMilenković, Dejan A., Marko N. Živanović, Milan S. Dekić, Marijana Stanojević Pirković y Jelena R. Đorović Jovanović. "CYTOTOXIC ACTIVITY AND MOLECULAR DOCKING STUDY OF 4- SUBSTITUTED FLAVYLIUM SALT". En 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac,, 2021. http://dx.doi.org/10.46793/iccbi21.466m.
Texto completoEkine-Afolabi, Bene Akromaa, Sandra Appiah, Azra Pachenari y Lucy Ghali. "Abstract LB-271: Inulin inhibits free radical species in HCT 116 adenoma carcinoma and normal human HK (keratinocyte) cell line". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-lb-271.
Texto completoPogorzelska, Aneta, Jarosław Sławiński y Anna Kawiak. "New N-Benzenesulfonylguanidine Derivatives and Their Selective Growth Inhibition of Human Breast Cancer Cell Line MCF-7 and Colon Carcinoma HCT-116". En ECMC 2022. Basel Switzerland: MDPI, 2022. http://dx.doi.org/10.3390/ecmc2022-13281.
Texto completoLee, Michael J., Robert J. M. Frey, Steven D. Frey, Anthony H. Yeo, Janna M. Vassantachart, Peter S. Han, Sara E. Stump, Ying Ming B. Tan, Randy P. Hausted y Brian YY Wong. "Abstract LB-21:Taraxacum officinale(common dandelion) inhibits azoxymethane-induced aberrant crypt foci formation in C67BL/6 mice and regulates apoptosis in mice and in human colorectal carcinoma HCT-116 cells". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-lb-21.
Texto completoHotta, Naoki. "IDDF2023-ABS-0005 Hepatocellular carcinoma (HCC) treatment experience using smart fusion in dialysis patients". En Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 10–11 June 2023. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2023. http://dx.doi.org/10.1136/gutjnl-2023-iddf.123.
Texto completoXu, Ming Jing, Kit Ho Lai, Shu Hai Lin, Pui Wah Tse, David Kung Chun Chiu, Hui Yu Koh, Cheuk Ting Law et al. "Abstract 1058: Targeting pentose phosphate pathway (PPP) represents a novel therapeutic strategy for hepatocellular carcinoma (HCC) treatment". En Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1058.
Texto completoCheo, Feng-Yi, Kai-Siang Chan, Wei-Xuan Tay y Vishal Shelat. "IDDF2022-ABS-0193 Outcomes of preoperative transarterial chemoembolization (TACE) compared to upfront liver resection for large (≥5cm) hepatocellular carcinoma (HCC): a systematic review and meta-analysis". En Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 2–4 September 2022. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2022. http://dx.doi.org/10.1136/gutjnl-2022-iddf.119.
Texto completoEl-Khoueiry, Anthony, Mary F. Mulcahy, Tanios Bekaii-Saab, Richard Kim, Crystal Denlinger, Rakesh Goel, Shweta Gupta et al. "Abstract 2947: Pharmacodynamic (PD) and pharmacokinetic (PK) results of the second-generation hypomethylating agent, SGI-110, in patients with hepatocellular carcinoma (HCC) after progression on sorafenib". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-2947.
Texto completoTrochon-joseph, Véronique, Caroline Lemarchand, Vincent Hayes, Yamina Rayah, Jean-Louis Labernardière y Graham Dixon. "Abstract 2143: Mechanistic study of the relative cytotoxicity of doxorubicin loaded nanoparticle formulation compared to free doxorubicin in hepatocellular carcinoma (HCC) cell lines". En Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2143.
Texto completo